Literature DB >> 18066052

Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation.

Eric Metzger1, Na Yin, Melanie Wissmann, Natalia Kunowska, Kristin Fischer, Nicolaus Friedrichs, Debasis Patnaik, Jonathan M G Higgins, Noelle Potier, Karl-Heinz Scheidtmann, Reinhard Buettner, Roland Schüle.   

Abstract

Posttranslational modifications of histones such as methylation, acetylation and phosphorylation regulate chromatin structure and gene expression. Here we show that protein-kinase-C-related kinase 1 (PRK1) phosphorylates histone H3 at threonine 11 (H3T11) upon ligand-dependent recruitment to androgen receptor target genes. PRK1 is pivotal to androgen receptor function because PRK1 knockdown or inhibition impedes androgen receptor-dependent transcription. Blocking PRK1 function abrogates androgen-induced H3T11 phosphorylation and inhibits androgen-induced demethylation of histone H3. Moreover, serine-5-phosphorylated RNA polymerase II is no longer observed at androgen receptor target promoters. Phosphorylation of H3T11 by PRK1 accelerates demethylation by the Jumonji C (JmjC)-domain-containing protein JMJD2C. Thus, phosphorylation of H3T11 by PRK1 establishes a novel chromatin mark for gene activation, identifying PRK1 as a gatekeeper of androgen receptor-dependent transcription. Importantly, levels of PRK1 and phosphorylated H3T11 correlate with Gleason scores of prostate carcinomas. Finally, inhibition of PRK1 blocks proliferation of androgen receptor-induced tumour cell proliferation, making PRK1 a promising therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18066052      PMCID: PMC2878724          DOI: 10.1038/ncb1668

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  19 in total

1.  Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference.

Authors:  Maciej Wiznerowicz; Didier Trono
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

Review 2.  Phosphorylation and functions of the RNA polymerase II CTD.

Authors:  Hemali P Phatnani; Arno L Greenleaf
Journal:  Genes Dev       Date:  2006-11-01       Impact factor: 11.361

3.  Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors.

Authors:  Ivan Garcia-Bassets; Young-Soo Kwon; Francesca Telese; Gratien G Prefontaine; Kasey R Hutt; Christine S Cheng; Bong-Gun Ju; Kenneth A Ohgi; Jianxun Wang; Laure Escoubet-Lozach; David W Rose; Christopher K Glass; Xiang-Dong Fu; Michael G Rosenfeld
Journal:  Cell       Date:  2007-02-09       Impact factor: 41.582

4.  Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression.

Authors:  Melanie Wissmann; Na Yin; Judith M Müller; Holger Greschik; Barna D Fodor; Thomas Jenuwein; Christine Vogler; Robert Schneider; Thomas Günther; Reinhard Buettner; Eric Metzger; Roland Schüle
Journal:  Nat Cell Biol       Date:  2007-02-04       Impact factor: 28.824

5.  Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.

Authors:  Philip Kahl; Lucia Gullotti; Lukas Carl Heukamp; Susanne Wolf; Nicolaus Friedrichs; Roland Vorreuther; Gerold Solleder; Patrick J Bastian; Jörg Ellinger; Eric Metzger; Roland Schüle; Reinhard Buettner
Journal:  Cancer Res       Date:  2006-12-01       Impact factor: 12.701

6.  LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription.

Authors:  Eric Metzger; Melanie Wissmann; Na Yin; Judith M Müller; Robert Schneider; Antoine H F M Peters; Thomas Günther; Reinhard Buettner; Roland Schüle
Journal:  Nature       Date:  2005-08-03       Impact factor: 49.962

7.  Ligand-specific allosteric regulation of coactivator functions of androgen receptor in prostate cancer cells.

Authors:  Sung Hee Baek; Kenneth A Ohgi; Charles A Nelson; Derek Welsbie; Charlie Chen; Charles L Sawyers; David W Rose; Michael G Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

8.  Nucleosome arrays inhibit both initiation and elongation of transcripts by bacteriophage T7 RNA polymerase.

Authors:  T E O'Neill; M Roberge; E M Bradbury
Journal:  J Mol Biol       Date:  1992-01-05       Impact factor: 5.469

9.  PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation.

Authors:  Alessio Zippo; Alessandra De Robertis; Riccardo Serafini; Salvatore Oliviero
Journal:  Nat Cell Biol       Date:  2007-07-22       Impact factor: 28.824

10.  Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity.

Authors:  Stanley S Ng; Kathryn L Kavanagh; Michael A McDonough; Danica Butler; Ewa S Pilka; Benoit M R Lienard; James E Bray; Pavel Savitsky; Opher Gileadi; Frank von Delft; Nathan R Rose; John Offer; Johanna C Scheinost; Tomasz Borowski; Michael Sundstrom; Christopher J Schofield; Udo Oppermann
Journal:  Nature       Date:  2007-06-24       Impact factor: 49.962

View more
  93 in total

Review 1.  A peek into the complex realm of histone phosphorylation.

Authors:  Taraswi Banerjee; Debabrata Chakravarti
Journal:  Mol Cell Biol       Date:  2011-10-17       Impact factor: 4.272

2.  Protein phosphatase 1γ is responsible for dephosphorylation of histone H3 at Thr 11 after DNA damage.

Authors:  Midori Shimada; Mayumi Haruta; Hiroyuki Niida; Kazunobu Sawamoto; Makoto Nakanishi
Journal:  EMBO Rep       Date:  2010-10-15       Impact factor: 8.807

3.  Structure of an SspH1-PKN1 complex reveals the basis for host substrate recognition and mechanism of activation for a bacterial E3 ubiquitin ligase.

Authors:  Alexander F A Keszei; Xiaojing Tang; Craig McCormick; Elton Zeqiraj; John R Rohde; Mike Tyers; Frank Sicheri
Journal:  Mol Cell Biol       Date:  2013-11-18       Impact factor: 4.272

4.  Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1.

Authors:  Changmeng Cai; Housheng Hansen He; Sen Chen; Ilsa Coleman; Hongyun Wang; Zi Fang; Shaoyong Chen; Peter S Nelson; X Shirley Liu; Myles Brown; Steven P Balk
Journal:  Cancer Cell       Date:  2011-10-18       Impact factor: 31.743

Review 5.  Chatting histone modifications in mammals.

Authors:  Annalisa Izzo; Robert Schneider
Journal:  Brief Funct Genomics       Date:  2010-12       Impact factor: 4.241

Review 6.  Histone demethylases and cancer.

Authors:  Sotirios C Kampranis; Philip N Tsichlis
Journal:  Adv Cancer Res       Date:  2009       Impact factor: 6.242

7.  Protein Kinase N1 control of androgen-responsive serum response factor action provides rationale for novel prostate cancer treatment strategy.

Authors:  Varadha Balaji Venkadakrishnan; Adam D DePriest; Sangeeta Kumari; Dhirodatta Senapati; Salma Ben-Salem; Yixue Su; Giridhar Mudduluru; Qiang Hu; Eduardo Cortes; Elena Pop; James L Mohler; Gissou Azabdaftari; Kristopher Attwood; Rajal B Shah; Christina Jamieson; Scott M Dehm; Cristina Magi-Galluzzi; Eric Klein; Nima Sharifi; Song Liu; Hannelore V Heemers
Journal:  Oncogene       Date:  2019-02-11       Impact factor: 9.867

8.  Lysine-specific demethylase 1 has dual functions as a major regulator of androgen receptor transcriptional activity.

Authors:  Changmeng Cai; Housheng Hansen He; Shuai Gao; Sen Chen; Ziyang Yu; Yanfei Gao; Shaoyong Chen; Mei Wei Chen; Jesse Zhang; Musaddeque Ahmed; Yang Wang; Eric Metzger; Roland Schüle; X Shirley Liu; Myles Brown; Steven P Balk
Journal:  Cell Rep       Date:  2014-12-04       Impact factor: 9.423

9.  PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis.

Authors:  Weiwei Yang; Yan Xia; David Hawke; Xinjian Li; Ji Liang; Dongming Xing; Kenneth Aldape; Tony Hunter; W K Alfred Yung; Zhimin Lu
Journal:  Cell       Date:  2012-08-17       Impact factor: 41.582

10.  Screen for DNA-damage-responsive histone modifications identifies H3K9Ac and H3K56Ac in human cells.

Authors:  Jorrit V Tjeertes; Kyle M Miller; Stephen P Jackson
Journal:  EMBO J       Date:  2009-04-30       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.